What is microvascular angina?

Written in association with: Dr Giovanni Luigi De Maria
Published: | Updated: 21/11/2024
Edited by: Carlota Pano

Microvascular angina is a lesser-known form of heart-related chest pain that can have a profound impact on daily life.

 

Dr Giovanni Luigi De Maria, distinguished consultant interventional cardiologist, explores what microvascular angina is, its symptoms, how it differs from traditional angina, and the latest treatment approaches aimed at managing this condition.

 

 

What is microvascular angina?

 

Microvascular angina is a condition caused by dysfunction in the small blood vessels of the heart, known as the coronary microvasculature. These vessels usually transport blood to the heart muscle, but in people with microvascular angina, the coronary microvasculature constrict and don’t function properly, limiting blood flow to the heart.

 

The most common symptom of microvascular angina is chest pain, which is often described as a tight, heavy, or squeezing sensation. This pain may radiate to the arms, neck, jaw, or back. Other common symptoms also include shortness of breath and persistent fatigue, even without strenuous activity. These symptoms may come and go and can occur even when at rest.

 

Microvascular angina is often linked to risk factors such as high blood pressure, diabetes, high cholesterol, and a family history of heart disease. Stress, obesity, and smoking can also increase the likelihood.

 

Is microvascular angina the same as typical angina?

 

Typical angina, also known as obstructive or stable angina, is generally caused by atherosclerosis, where plaques of fatty substances build up inside the larger coronary arteries, leading to blockages or narrowing. These blockages restrict blood flow to the heart muscle, resulting in pain during physical activity or emotional stress, which subsides with medications or after surgical procedures to clear the blockages.

 

In contrast, microvascular angina occurs without visible blockages in the large coronary arteries. Instead, it’s related to dysfunction of the endothelium (the inner lining) in the small blood vessels, which prevents the vessels from dilating as needed. This reduced blood flow may not be easily visible on standard angiograms, as these imaging tests primarily focus on the larger coronary arteries.

 

How is microvascular angina treated?

 

Unlike typical angina, microvascular angina can’t be treated with procedures like angioplasty or stenting, as these directly relieve blockages in the larger coronary arteries. Instead, treatment for microvascular angina generally involves medication, lifestyle changes, and addressing risk factors.

 

Medications commonly prescribed for microvascular angina include beta-blockers and calcium channel blockers, which reduce heart rate and the demand on the heart. Nitrates can help dilate and widen blood vessels, while statins are often prescribed to reduce inflammation. Additionally, aspirin or other antiplatelet medications may be recommended to prevent clot formation.

 

Lifestyle modifications are also essential in managing microvascular angina. Adopting a heart-healthy diet, engaging in regular physical activity, managing stress, and quitting smoking can significantly improve heart health and alleviate symptoms. For people with hypertension or diabetes, managing these conditions effectively is crucial to reduce the impact on the microvascular system.

 

In some cases, a cardiac rehabilitation programme can provide structured exercise routines and support for making these lifestyle changes.

 

Can microvascular angina lead to heart failure or other complications?

 

Microvascular angina is less likely to cause a heart attack than typical angina, but it can still have significant long-term effects. Over time, reduced blood flow in the small vessels can lead to chronic ischaemia, or insufficient oxygen supply to the heart muscle. This can weaken the heart’s ability to pump blood effectively, increasing the risk of developing heart failure.

 

In addition, ongoing symptoms of chest pain, shortness of breath, and fatigue can lead to frequent visits to the hospital and interference with daily activities. These factors can contribute to anxiety, depression, and reduced quality of life.

 

Long-term outcomes for people with microvascular angina vary. Medications, lifestyle adjustments, and regular monitoring can help to prevent symptoms from worsening and reduce the risk of further cardiovascular events. However, the chronic nature of microvascular angina means that symptoms may persist or recur, and ongoing management is required to keep the condition under control.

 

 

If you would like to book an appointment with Dr Giovanni Luigi De Maria, head on over to his Top Doctors profile today.

By Dr Giovanni Luigi De Maria
Cardiology

Dr Giovanni Luigi De Maria is a distinguished consultant interventional cardiologist who is based in Oxford. He specialises in coronary heart disease, hypertension, coronary angioplasty, chest pain, and interventional cardiology.

Dr Giovanni Luigi De Maria qualified in medicine with an MD from the Catholic University of the Sacred Heart in Rome, Italy in 2008. Following this, he undertook general cardiology training at Gemelli Hospital in Rome  in 2014. He later completed a clinical fellowship in interventional cardiology at the John Radcliffe Hospital in Oxford, along with a British Research Council fellowship at the University of Oxford. In 2019, he was awarded a PhD in 'Clinical, cellular, and molecular research' at the Catholic University of the Sacred Heart of Rome.

Dr Giovanni Luigi De Maria has served as a consultant interventional cardiologist at the John Radcliffe Hospital, Oxford since 2019.

In addition to his clinical responsibilities, Dr De Maria holds a number of senior positions, including lead of the Acute Cardiovascular sub-theme at the Oxford British Research Council and he is clinical lead of the Research Catheterization Laboratory of the Acute Multidisciplinary Imaging and Intervention Centre (AMIIC) at the University of Oxford.

He is also a leading name in medical education, and regularly teaches and trains junior doctors and acts as a supervisor for PhD students and both clinical and research fellows. He has also served as a faculty member on numerous international cardiology courses, and has appeared as a speaker and live operator in a number of key national and international conferences and workshops.

Dr Giovanni Luigi De Maria has an extensive background in research and continues to be involved in a number of key clinical trials. He has authored over 130 academic articles which appear in peer-reviewed journals, as well as several book chapters. He currently serves as associate editor for Frontiers Cardiovascular Medicine – Cardiovascular Imaging, and acts as a reviewer for various other academic journals, including JACC Cardiovascular Imaging, EuroIntervention and the International Journal of Cardiology.

Throughout his esteemed career, Dr Giovanni Luigi De Maria has received various awards in recognition of the excellence of his work, including the prize for best abstract from the Italian Society of Interventional Cardiology in 2009, and the Young Investigator Award in Advanced Cardiovascular Intervention from the British Cardiovascular Intervention Society in 2017.

View Profile

Overall assessment of their patients


  • Related procedures
  • Heart attack
    Arrhythmia
    Hypertension (high blood pressure)
    Pericarditis
    Heart failure
    Injury valves
    Heart murmur
    Echocardiogram
    Electrocardiogram
    Ambulatory electrocardiogram (Holter)
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.